Clinical Trial Update: Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating neoadjuvant PD-1 monoclonal antibody plus cisplatin-based chemotherapy for locally advanced upper tract urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• PD-1 monoclonal antibody
• cisplatin-based chemotherapy (cisplatin)

Snippet

Sponsor: RenJi Hospital | Conditions: Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma | Phase 2 | Status: UNKNOWN